Literature DB >> 2428096

Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease.

M Bohe, S Genell, K Ohlsson.   

Abstract

The level and functional activity of the major protease inhibitors in plasma and faecal extracts were analysed in 26 consecutive patients admitted during their first attack of acute severe colitis. The patients were retrospectively divided into two groups: one with total colitis and another with distal colitis. The patients with total colitis had a significantly lower alpha 2-macroglobulin level in plasma than normal individuals and patients with distal disease, whereas no difference in the levels of alpha 1-protease inhibitor, antichymotrypsin, antithrombin III, and alpha 2-antiplasmin was noted between the two groups. The protease-inhibiting capacity was saturated, and free proteolytic activity was present in the faecal extracts. In the extracts complex formation was demonstrated between leukocyte proteases and the antiproteases alpha 1-protease inhibitor and alpha 2-macroglobulin. It is concluded that the low plasma level of alpha 2-macroglobulin in patients with severe total colitis is mainly due to a consumption caused by complex formation with proteases, as earlier demonstrated in patients with acute pancreatitis and sepsis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428096     DOI: 10.3109/00365528609003106

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Significance of microflora in proteolysis in the colon.

Authors:  S A Gibson; C McFarlan; S Hay; G T MacFarlane
Journal:  Appl Environ Microbiol       Date:  1989-03       Impact factor: 4.792

2.  Molecular form of faecal alpha 1 antitrypsin in patients with Crohn's disease.

Authors:  C Mizon; J eL Yamani; J Mizon; J F Colombel; A Cortot
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  J H Ware; X S Wan; P Newberne; A R Kennedy
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

4.  Protease activity in a hapten-induced model of ulcerative colitis in rats.

Authors:  J V Hawkins; E L Emmel; J J Feuer; M A Nedelman; C J Harvey; H J Klein; H Rozmiarek; A R Kennedy; G R Lichtenstein; P C Billings
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.